Clinical Research Directory
Browse clinical research sites, groups, and studies.
MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy
Sponsor: Fujian Cancer Hospital
Summary
This study aims to validate the value of tumor involvement features based on MRI in cervical cancer, facilitate the development of a more appropriate model for risk stratification, and help patients with varying risk profiles make appropriate decisions in treatment selection and follow-up plans.
Official title: A Prognostic Model Based on MRI for Cervical Cancer Patients Treated With Radiotherapy
Key Details
Gender
FEMALE
Age Range
20 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-01-01
Completion Date
2028-12-31
Last Updated
2024-01-09
Healthy Volunteers
No
Interventions
Treatment mainly composed of external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT) .
The chemotherapy regimens included cisplatin (40 mg/m2) or nedaplatin (80 mg/m2) monotherapy or combined with paclitaxel (135 mg/m2) every three weeks during radiotherapy.
Locations (1)
Fujian Cancer Hospital
Fuzhou, Fujian, China